Genesis Medical Vision
Early Detection of Cancer Ai Platform
Company Overview
Snapshot
Founded in November 2022 by Shay Cohen, Prof. Natan, and Iliya Kusner, Genesis Medical Vision operates with 1–10 employees. The company has raised $2.71M across four funding rounds. In February 2025, Dover Medical led a Pre-Seed funding round for the company.
Business overview
Genesis Medical Vision is at the forefront of AI in radiology, developing an AI platform for the early detection of cancer. The company utilizes a non-statistical, clinical AI-education methodology designed to mimic the logic and intuition of an expert physician, requiring minimal scans to achieve high accuracy with near-zero false positives. Operating within the Health Tech & Life Sciences sector, specifically Digital Healthcare and Digital Medical Diagnostics, Genesis Medical Vision serves the healthcare industry with a focus on providers in markets such as the United States and Europe.
Strategic signal
Genesis Medical Vision is actively engaged in advancing its technology through clinical validation, as evidenced by its ongoing clinical trial for lung cancer screening. This initiative, highlighted in July 2025, aims to develop and validate new methods or technologies, signaling a strong commitment to product development and market readiness in the critical area of cancer diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- What is Genesis Medical Vision's primary focus?
- Genesis Medical Vision specializes in pioneering AI in radiology for the early detection of cancer, employing a non-statistical, clinical AI-education methodology.
- When was Genesis Medical Vision founded and by whom?
- Genesis Medical Vision was founded in November 2022 by Shay Cohen, Prof. Natan, and Iliya Kusner.
- What was a significant recent funding event for Genesis Medical Vision?
- In February 2025, Genesis Medical Vision secured a Pre-Seed funding round led by.
- Has Genesis Medical Vision received any grants?
- In March 2024, Genesis Medical Vision secured a grant from the Israel Innovation Authority.
- What is Genesis Medical Vision's current product development stage?
- Genesis Medical Vision's product, G4Lungs, is currently in the Beta stage, as of January 2024. The company is conducting a clinical trial for lung cancer screening to develop and validate new methods or technologies.